AngloGold Ashanti (AU) Is Up 7.35% in One Week: What You Should Know — Positive

AU   Zacks Investment Research — October 08, 2025

Does AngloGold Ashanti (AU) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news AngloGold Ashanti (AU) Is Up 7.35% in One Week: What You Should Know

Victory Capital (VCTR) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive

VCTR   Zacks Investment Research — October 08, 2025

Victory Capital (VCTR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Victory Capital (VCTR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Intellia Therapeutics (NTLA) Upgraded to Buy: Here's What You Should Know — Positive

NTLA   Zacks Investment Research — October 08, 2025

Intellia Therapeutics (NTLA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Intellia Therapeutics (NTLA) Upgraded to Buy: Here's What You Should Know

All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy — Positive

LFST   Zacks Investment Research — October 08, 2025

LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy

Carnival (CCL) Upgraded to Strong Buy: Here's Why — Positive

CCL   Zacks Investment Research — October 08, 2025

Carnival (CCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news Carnival (CCL) Upgraded to Strong Buy: Here's Why

All You Need to Know About Willis Towers Watson (WTW) Rating Upgrade to Buy — Positive

WTW   Zacks Investment Research — October 08, 2025

Willis Towers Watson (WTW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news All You Need to Know About Willis Towers Watson (WTW) Rating Upgrade to Buy

Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade — Positive

CGTX   Zacks Investment Research — October 08, 2025

Cognition Therapeutics (CGTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade

The Big 3: VIX, TOL, TLT — Neutral

TLT   Schwab Network — October 08, 2025

@Theotrade's Don Kaufman is a bull when it comes to the CBOE Volatility Index (VIX), though he's a bear when it comes to Toll Brothers (TOL) and the iShares 20+ year Treasury Bond ETF (TLT). He explains why he sees an uptrend in volatility creating a vortex for stocks and bonds.

image for news The Big 3: VIX, TOL, TLT

3 Quantum Computing Stocks that Could Be The Next Nvidia — Neutral

IONQ  QBTS  RGTI   24/7 Wall Street — October 08, 2025

As Wall Street's AI darling, Nvidia (Nasdaq: NVDA) is one of those wonders that appear to come along once in a lifetime.

image for news 3 Quantum Computing Stocks that Could Be The Next Nvidia

LCNB Corp. Solidifies Leadership Team to Support Growth — Neutral

LCNB   Business Wire — October 08, 2025

LEBANON, Ohio--(BUSINESS WIRE)--LCNB Corp. (Nasdaq: LCNB, the “Company”) today announced several leadership promotions as part of its comprehensive succession plan, reinforcing the Company's management depth and supporting its long-term strategic growth. “Enhancing LCNB's leadership structure to support a larger, more complex business is an important part of our longstanding succession plan. It also reflects the success of our multi-year growth plan, as LCNB's total assets managed has increased.

image for news LCNB Corp. Solidifies Leadership Team to Support Growth

Although data perimeters are considered an advanced practice, over one-third of organizations have already adopted them New York, New York--(Newsfile Corp. - October 8, 2025) - Datadog, Inc. (NASDAQ: DDOG), the monitoring and security platform for cloud applications, today announced the 2025 version of its State of Cloud Security report. In it, Datadog found that newer strategies—such as data perimeters and centrally managed multi-account environments—are growing in popularity.

image for news Datadog's 2025 State of Cloud Security Report Finds Companies Adopting Data Perimeters Amid Growing Concerns of Credential Theft

LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave, Inc. (Nasdaq: CRWV), the AI Hyperscaler™, today announced the launch of Serverless RL, a fast and easy way to train AI agents using reinforcement learning (RL). The first publicly available fully managed RL capability, Serverless RL scales seamlessly to dozens of GPUs, requires only a Weights & Biases account and API key to get started, and delivers faster feedback loops with lower barriers to entry for developers. This new capability launches j.

image for news CoreWeave Launches First Publicly Available Serverless Reinforcement Learning Capability to Build Reliable AI Agents

Salesforce said on Wednesday it would spend $1 billion in Mexico over the next five years, as the cloud software provider looks to expand its operations and drive artificial intelligence adoption.

image for news Salesforce to spend $1 billion in Mexico over next five years to drive AI adoption

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Palantir Technologies Inc. (“Palantir” or the “Company”) (NASDAQ: PLTR) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PALANTIR TECHNOLOGIES INC. (PLTR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Ha.

image for news Securities Fraud Investigation Into Palantir Technologies Inc. (PLTR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Brinker International remains fundamentally strong despite recent stock pullback, with robust growth at Chili's and an attractive 12x forward PE valuation. Growth is moderating but still outpaces the industry, with management guiding 4-6% revenue growth for FY26 and likely conservative estimates for the first quarter. Long-term drivers include operating leverage, share repurchases, and a potential turnaround at Maggiano's, supporting double-digit bottom-line growth targets.

image for news Brinker International: Recent Dip Could Be An Opportunity Before A Potential Q1 2026 Surprise

PGY Closes $400M RPM Deal: A Move to Further Diversify Funding? — Neutral

PGY   Zacks Investment Research — October 08, 2025

Pagaya announces closing of RPM 2025-5, a $400-million auto loan-backed ABS deal, marking its fifth ABS transaction in 2025.

image for news PGY Closes $400M RPM Deal: A Move to Further Diversify Funding?

Oscar Health: What The US Government Shutdown Means To The Company — Positive

OSCR   Seeking Alpha — October 08, 2025

Oscar Health (OSCR) faces uncertainty as the expiration of enhanced ACA premium tax credits could impact membership and margins. Oscar's growth is supported by rising Individual Coverage Health Reimbursement Arrangements (ICHRA), expanding its addressable market and revenue potential. If subsidies are extended, Oscar will able to continue to grow their member base and eventually reach profitability.

image for news Oscar Health: What The US Government Shutdown Means To The Company

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio — Positive

MCK   Zacks Investment Research — October 08, 2025

MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.

image for news McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio

Marvell: The Market Won't Ignore Its Coming AI Boom For Long — Positive

MRVL   Seeking Alpha — October 08, 2025

Marvell Technology is well-poised to benefit from the secular AI infrastructure growth and robust demand for high-speed networking solutions. MRVL's revenue visibility is underpinned by a strong partnership with AWS, amid ongoing diversification efforts, while facing some skepticism over its smaller custom compute share. Wall Street estimates for MRVL earnings are still trending higher, yet the stock remains well below its early 2025 peak, presenting a stark disconnect.

image for news Marvell: The Market Won't Ignore Its Coming AI Boom For Long

Rocket Lab's Shares Lift on New Multi-Mission Satellite Launch Deals — Positive

RKLB   Investopedia — October 08, 2025

Shares of Rocket Lab (RKLB) traded at a record high when the satellite launch provider announced details about several planned missions.

image for news Rocket Lab's Shares Lift on New Multi-Mission Satellite Launch Deals